Use our keyword search facility to match our publications with your area of interest.  Alternatively, you may locate the titles organised within latest year date below.

Enter relevant Keyword(s)
 Match all words (Returns only matches that contain ALL the words entered)
 Match Case (Ignores matching words if the case differs from those entered)
 Find whole words only (Ignores words entered if they are part of another word)
Publications by Date
2008 Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users: A Cohort Study Using Pharmacy Dispensing Data in The Netherlands.
2007 The Safety Profiles of Orlistat and Sibutramine: Results of Prescription-Event Monitoring Studies in England.
2007 Safety of nateglinide as used in general practice in England: results of a prescription-event monitoring study.
2007 Pharmacovigilance
2007 A modified Prescription-Event Monitoring study to assess the introduction of Flixotide EvohalerTM into general practice in England: An example of pharmacovigilance planning and risk monitoring.
2007 A Modified Prescription-Event Monitoring Study to Assess the Introduction of Seretide EvohalerTM in England. An Example of Studying Risk Monitoring in Pharmacovigilance.
2007 The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England.
2007 Prescription-Event Monitoring. Developments in Signal Detection.
2007 Thoughts on Signal Detection in Pharmacovigilance.
2007 Safety of Zafirlukast. Results of a Postmarketing Surveillance Study on 7976 Patients in England.
2007 Application of the Bradford Hill Criteria to Assess the Causality of Cisapride-Induced Arrhythmia:
A Model for Assessing Causal Association in Pharmacovigilance.
2007 An analysis of the exclusion criteria used in observational pharmacoepidemiological studies.
2007 PEM in the UK.
2007 Prescription Event Monitoring.
2007 An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease.
2007 Safety Profile of Rosuvastatin: Results of a Prescription-Event Monitoring Study of 11680 Patients.
2006 Safety profile of orlistat: results of a prescription-event monitoring study.
2006 Comparison of the Risk of Drowsiness and Sedation between Levocetirizine and Desloratadine.
2006 Exposure to Mirtazapine During Pregnancy: A Prospective, Comparative Study of Birth Outcomes.
2006 Serious Skin Reactions and Selective COX-2 Inhibitors. A Case Series From Prescription-Event Monitoring In England.
2006 Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction.
2006 Under-reporting of Adverse Drug Reactions: A Systematic Review.
2006 Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study.
2006 Bill Inman: a drug safety physician and pharmacoepidemiologist.
2006 Ophthalmological Events in Patients Receiving Risedronate.
2005 Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England.
2006 An Assessment of the Publicly Disseminated Evidence of Safety Used in Decisions to Withdraw Medicinal Products from the UK and US Markets.
2005 A Comparison of Reported Gastrointestinal and Thromboembolic Events between Rofecoxib and Celecoxib Using Observational Data.
2005 Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
2005 Prescription-Event Monitoring.
2005 The Safety and Effectiveness of Newer Antiepileptics; A Comparative Postmarketing Cohort Study.
2005 Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study.
2005 Pregnancy outcome of women using atypical antipsychotic drugs: A prospective comparative study.
2005 Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring study of YasminŽ.
2005 The negative effect of red tape on research.
2005 Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study.
2004 Hospital admissions for ‘drug-induced’ disorders in England: a study using the Hospital Episodes Statistics (HES) database.
2004 Do Some Inhibitors of COX-2 Increase the Risk of Thromboembolic Events? Linking Pharmacology with Pharmacoepidemiology.
2004 Identification and evaluation of a possible signal of exacerbation of colitis during rofecoxib treatment, using Prescription-Event Monitoring data.
2004 Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999
2003 Causality and Correlation in Pharmacovigilance
2003 Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000
2003 Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.
2003 Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.
2003 Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.
2003 Pharmacovigilance study of alendronate in England.
2003 Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data.
2003 Relative Risk of Vaginal Candidiasis After Use of Antibiotics Compared with Antidepressants in Women
2003 The Pharmacovigilance of Mirtazapine: results of a prescription event monitoring study on 13554 patients in England.
2003 Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study
2003 The Pharmacovigilance of Pantoprazole. The results of Postmarketing Surveillance on 11541 Patients in England
2003 Prospective observational cohort safety study to monitor the introduction of a non-CFC formulation of salbutamol with HFA134a in England
2003 Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future.
2002 The safety of Valsartan: Result of a Post-Marketing surveillance study on 12881 Patients in England
2002 Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK
2002 PEM in the UK. In:Pharmacovigilance. Eds:R D Mann and E Andrews
2002 A Postmarketing Surveillance Study of Gabapentin as Add-on Therapy for 3,100 Patients in England
2002 A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil
2002 Automated Signal Generation in Prescription-Event Monitoring
2002 Causal Association in Pharmacovigilance and Pharmacoepidemiology - Thoughts on the Application of the Austin Bradford-Hill Criteria
2002 A post-marketing observational study to assess the safety of mibefradil in the community in England
2002 A Post-Marketing Surveillance Study of Formoterol (ForadilŽ) Its Use in General Practice in England
2002 Results of a postal survey of the reasons for non-response by doctors in a Prescription-Event Monitoring study of drug safety
2001 Profiles of Hepatic and Dysrhythmic Cardiovascular Events Following Use of Fluoroquinolone Antibacterials. Experience from Large Cohorts from the Drug Safety Research Unit Prescription-Event Monitoring Database
2001 Principles of Pharmacovigilance
2001 Prescription-event monitoring and reporting of adverse drug reactions
2001 Montelukast and improvement of eczema: observations from a prescription event monitoring study in England
2001 The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England
2001 Monitoring the Safety of Over the Counter (OTC) products
2001 Pharmacovigilance and community pharmacists
2001 Safety Profile of Tolterodine as Used in General Practice in England
2001 Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997
2001 Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine
2001 Finasteride and tamsulosin used in benign prostatic hypertrophy: a review of the prescription-event monitoring data
2001 Prospective cohort study of adverse events monitored by hospital pharmacists
2001 Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding?
2001 Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England
2001 Myocardial infarction and oral contraceptives
2001 Troglitazone and Liver Function Abnormalities
2000 Adverse effects associated with the use of donepezil in general practice in England
2000 The rates of common adverse -events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies
2000 Costs of seeking ethics approval before and after the introduction of multicentre research ethics committees
2000 The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study
2000 Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice
2000 Drug Safety Research Unit and pharmacoepidemiology
2000 The pharmacovigilance of tamsulosin: event data on 12,484 patients
2000 Regional variation in incidence and case fatality of myocardial infarction among young women in England, Scotland and Wales
1999 Newer antidepressants: a comparison of tolerability in general practice
1999 Antidepressants and the serotonin syndrome in general practice
1999 Did Knowledge, Opinions, Background, and Health Authority Advice Influence Early Prescribing of the Novel Alzheimer's Disease Drug Donepezil in General Practice? - National Postal Survey
1999 Visual field defect associated with vigabatrin: observational cohort study
1999 Risk of myocardial infarction in young female smokers
1999 Setting up Prescription-Event Monitoring for National Postmarketing Surveillance - Problems and Potential. In:Handbook of Drug Research Methodology 1st Edition, 2000. Ed. Hugh McGavock
1999 Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression
1999 Losartan ; a study of pharmacovigilance data on 14,522 patients
1999 Prescription-Event and other forms of epidemiological monitoring of side-effects in the UK
1999 Case and Control Recruitment, and Validation of Cases for the MICA Case-Control Study in England, Scotland and Wales
1999 Nefazodone in community use: the results of Prescription-event monitoring
1999 Safety Profile of Nicorandil - Prescription-Event Monitoring (PEM) Study
1999 Oral Contraceptives and myocardial infarction : results of the MICA case-control study
1999 Prevalence of Churg-Strauss Syndrome, Vasculitis, Eosinophilia and Associated Conditions : Retrospective Analysis of 58 Prescription-Event Monitoring Cohort Studies
1999 Nicorandil and Diabetes : A nested case-control study to examine a signal generated by Prescription-Event Monitoring
1999 The Use of Newly Marketed Drugs in Children and Adolescents Prescribed in General Practice
1999 Interim Report on the Incidence of Visual Field Defects in Patients on Long Term Vigabatrin Therapy
1999 Design of a pilot prospective cohort study of adverse events monitored by hospital pharmacists
1999 Cough and angiotensin II inhibitors : cause or confounding?
1998 UK postal survey of pharmacists working with general practices on prescribing issues: characteristics, roles and working arrangements
1998 Pharmacovigilance - the place and usefulness of observational cohort studies
1998 Adverse reactions and the science of pharmacosurveillance
1998 Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England : analysis of 48 cohort studies
1998 Post Marketing Studies - The Work of the Drug Safety Research Unit
1998 The Safety of Risperidone: a Post-Marketing Study on 7684 Patients
1998 The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England
1998 Study to Determine the Relationship Between Prescribed and Dispensed Drugs as Recorded in a Selection of Computerized General Pactices. 14th International Conference on Pharmacoepidemiology, Berlin
1998 Newer antidepressants: a comparison of tolerability. 14th International Conference on Pharmacoepidemiology, Berlin
1998 Age and Sex Specific Asthma Death Rates in Patients Taking Long Acting B2-agonists. 14th International Conference on Pharmacoepidemiology, Berlin
1998 Are Common Adverse Events Reported With The Same Frequency in Patients Taking Omeprazole Compared With Patients Taking Lansoprazole in General Practice in England? 14th International Conference on Pharmacoepidemiology, Berlin
1998 Trends in Presribing H2-receptor Antagonists and Proton Pump Inhibitors in Primary Care
1998 When to use a new drug
1998 Risk of non-fatal congestive cardiac failure and ischaemic heart disease long acting with B2-agonists
1998 Is the Incidence of Upper Respiratory Tract Infection Independent of Drug Treatment in Large Cohort Studies of Longer Term Use Drugs?
1998 Does good practice organization improve the outcome of care for diabetic patients?
1998 Oral contraceptives and thrombosis
1998 The Role of Prescribing and Referral Bias in Studies of the Association Between Third Generation Oral Contraceptives and Increased Risk of Thromboembolism
1998 United Kingdom experience with alendronate and oesophageal reactions
1998 Galactorrhoea with moclobemide
1998 Prescription-event monitoring - recent progress and future horizons
1998 Under-reporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study
1997 Oral contraceptives and myocardial infarction
1997 Myocardial Infarction and Oral Contraceptives, a Retrospective Case Control Study in England and Scotland ('MICA' Study)
1997 A Comparison of Fluvoxamine, Fluoxetine, Sertraline and Paroxetine Examined by Observational Cohort Studies
1997 Prescription-Event Monitoring (PEM) in 1996 - A Method of Non-Interventional Observational Cohort Pharmacovigilance
1997 Acarbose and Gastrointestinal Intolerance
1997 The Incidence of Hallucinations Associated With Tramadol
1997 Visual Field Defects in People taking Vigabatrin
1997 The incidence of the most commonly reported events with 40 newly marketed drugs - a study by Prescription-Event Monitoring
1997 Drug Safety and Pharmacovigilance. In: Integrated Pharmacology
1997 Safety of Long-Term Lamotrigine in Epilepsy
1997 A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV study
1997 Drug Safety Monitoring of 12692 Patients Treated with Fluoxetine
1996 Are Any of the Newer Anti-Epileptic Drugs Teratogenic? 12th International Conference on Pharmacoepidemiology, The Netherlands
1996 Cough with ACE Inhibitors: An Example of Reporting Bias in Observational Cohort Studies. 12th International Conference on Pharmacoepidemiology, The Netherlands
1996 Prescription-Event Monitoring and the Reporting of ADRs
1996 The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients
1996 A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies
1996 Salmeterol: A Study by Prescription-Event Monitoring in a UK cohort of 15,407 patients
1995 Adverse drug reactions and the adrenal glands - a pharmacoepidemiological approach In:The adrenal in Toxicology Target Organ and Modulation of Toxicity Ed:P Harvey Taylor & Francis, London
1995 Breast implants: The tyranny of the anecdote
1995 Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoring
1994 Terminology in prescription-event monitoring
1994 Databases and drug epidemiology - the situation in the UK
1994 Monitoring the Safety of Medicines. Ronald D Mann In:Clinical Research Manual
1994 Pharmacoepidemiology and the Pharmaceutical Industry.Ronald D Mann.In:Discovering New Medicines:Careers in Pharmaceutical Research & Development
1994 Identifying resources for assessing use and effects of pharmaceuticals and other medical products in the EC.In:European Medical Research. Ed.G.N. Fracchia
1994 Results of prescription event monitoring study of salmeterol
1994 Safety of Fluconazole in the treatment of vaginal candidiasis
1993 30 Years in Postmarketing Surveillance. A Personal Perspective
1993 PEM Report Number 6. Paroxetine
1993 Prescriber profile and post-marketing surveillance
1990 Prescription-Event Monitoring: Methodology and Recent Progress
1990 Prescription-Event Monitoring of Nabumetone
1990 Post-marketing Surveillance of Diltiazem by Prescription-Event Monitoring
1990 Prescription-Event Monitoring: An Example of Total Population Post-Marketing Drug Surveillance
1989 PMS and "Brass Tacks"
1988 Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure
1988 Post-marketing surveilance of enalapril. I: Results of prescription-event monitoring.
1988 Clinical Profile of Angioedema associated with Angiotensin Converting-Enzyme Inhibition
1988 Blood disorders and suicide in patients taking mianserin or amitriptyline
1986 Prescription-Event Monitoring - Recent experiences with 5 NSAIDs
1983 Yellow cards and green forms
1983 Erythromycin estolate and jaundice
1982 Prescription-Event Monitoring - A Preliminary Study of Benoxaprofen and Fenbufen
1981 Post-marketing surveillance of adverse drug reactions in general practice
1981 Contemporary Themes: Post-marketing surveillance of adverse drug reactions in general practice. I: Search for new methods
1980 Monitoring for Drug Safety. 2nd Edition Ed: WHW Inman
Unkn'n Requirements for risk-benefit assessment of drugs before withdrawal
Scroll the list
DSRU Education &        Research Limited